Abstract Purpose of Review This review highlights indications and evidence on laser
therapy in the management of diabetic retinopathy and diabetic macular edema. Particular …

Diabetic retinopathy is a major retinal disorder and a leading cause of blindness. Diabetic
macular edema (DME) is an ocular complication in patients with diabetes, and it can impair …

Yellow subthreshold micropulse laser (YSML) is a retinal laser capable of inducing a
biologic response without causing thermal damage to the targeted tissue. The 577-nm …

To compare the efficacy and safety of intravitreal aflibercept with three loading doses+ pro re
nata regimen combined with subthreshold laser application to that of IVA monotherapy on …

Macular edema (ME) is associated with various conditions; however, the main causes of ME
are retinal vein occlusion (RVO) and diabetes. Laser photocoagulation, formerly the gold …

Diabetic macular edema (DME) is one of the main causes of visual impairment in patients of
working age. DME occurs in 4% of patients at all stages of diabetic retinopathy. Using a …

Diabetic macular oedema (DMO) is the leading cause of vision loss associated with diabetic
eye disease. The exponential increase in the diabetic population and thus, of DMO is an …

Methods: A narrative review of English literature and publicly available information
published before November 2021 from literature databases and computerized texts. We …

Background Intravitreal injection anti-vascular endothelial growth factor (IVI anti-VEGF)
therapy serves as the primary treatment for centre involving diabetic macular oedema …

Intravitreal injection of anti-Vascular Endothelial Growth Factor (VEGF) is commonly used to
treat patients with diabetic macular edema (DME). However, the injection alone requires …